Megestrol Acetate Patent Expiration
Megestrol Acetate is Used for treating anorexia, cachexia, or unexplained significant weight loss in AIDS patients. It was first introduced by Bristol Myers Squibb
Megestrol Acetate Patents
Given below is the list of patents protecting Megestrol Acetate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Megace Es | US7101576 | Nanoparticulate megestrol formulations |
Apr 22, 2024
(Expired) | Endo Operations |
Megace Es | US9040088 | Nanoparticulate megestrol formulations |
Apr 22, 2024
(Expired) | Endo Operations |
Megace Es | US9101540 | Nanoparticulate megestrol formulations |
Apr 22, 2024
(Expired) | Endo Operations |
Megace Es | US9101549 | Nanoparticulate megestrol formulations |
Apr 22, 2024
(Expired) | Endo Operations |
Megace Es | US9107827 | Nanoparticulate megestrol formulations |
Apr 22, 2024
(Expired) | Endo Operations |
Megace Es | US6592903 | Nanoparticulate dispersions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
Sep 21, 2020
(Expired) | Endo Operations |
Megestrol Acetate's Family Patents

Explore Our Curated Drug Screens
Megestrol Acetate Generic API Manufacturers
Several generic applications have been filed for Megestrol Acetate. The first generic version for Megestrol Acetate was by Usl Pharma Inc and was approved on Oct 2, 1987. And the latest generic version is by Chartwell Life Molecules Llc and was approved on Dec 1, 2017.
Given below is the list of companies who have filed for Megestrol Acetate generic, along with the locations of their manufacturing plants worldwide.
1. BARR
Barr Laboratories Inc has filed for 2 different strengths of generic version for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Barr.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
40MG | tablet | Prescription | ORAL | AB | Nov 30, 1995 |
20MG | tablet | Prescription | ORAL | AB | Aug 16, 1996 |
Manufacturing Plant Locations New
Barr's manufacturing plants are situated in 4 countries - Mexico, Singapore, United States, Philippines. Given below are the details of these plant locations as well as the firm names of Barr as present at those locations.
Country | City | Firm Name | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mexico |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Singapore |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
United States |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Philippines |
|
2. CHARTWELL
Chartwell Life Molecules Llc has filed for 1 generic for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Chartwell.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
125MG/ML | suspension | Discontinued | ORAL | N/A | Dec 1, 2017 |
Manufacturing Plant Locations New
Chartwell's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Chartwell as present at those locations.
Country | City | Firm Name | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
|
3. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
20MG | tablet | Discontinued | ORAL | N/A | Sep 29, 1995 |
40MG | tablet | Discontinued | ORAL | N/A | Sep 29, 1995 |
40MG/ML | suspension | Discontinued | ORAL | N/A | Jun 9, 2017 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
Portugal |
| |||||||||
Jordan |
|
4. NOVITIUM PHARMA
Novitium Pharma Llc has filed for 1 generic for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Novitium Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
40MG/ML | suspension | Prescription | ORAL | AB | Feb 16, 2006 |
Manufacturing Plant Locations New
Novitium Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Novitium Pharma as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
5. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Strides Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
40MG
(reference standard) | tablet | Prescription | ORAL | AB | Aug 8, 1988 |
20MG | tablet | Prescription | ORAL | AB | Aug 8, 1988 |
40MG/ML
(reference standard) | suspension | Prescription | ORAL | AB | Jul 25, 2001 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
| |||||
India |
|
6. TEVA
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Teva.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
40MG | tablet | Discontinued | ORAL | N/A | Feb 27, 1998 |
Manufacturing Plant Locations New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
India |
| |||||||||
Canada |
| |||||||||
Czech Republic |
| |||||||||
Ireland |
| |||||||||
Israel |
|
7. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 1 generic for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Teva Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
40MG/ML | suspension | Discontinued | ORAL | N/A | May 5, 2003 |
8. TWI PHARMS
Twi Pharmaceuticals Inc has filed for 1 generic for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Twi Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
125MG/ML
(reference standard) | suspension | Prescription | ORAL | N/A | Aug 27, 2014 |
9. USL PHARMA
Usl Pharma Inc has filed for 2 different strengths of generic version for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Usl Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
20MG | tablet | Discontinued | ORAL | N/A | Oct 2, 1987 |
40MG | tablet | Discontinued | ORAL | N/A | Oct 2, 1987 |
10. XTTRIUM LABS INC
Xttrium Laboratories Inc has filed for 1 generic for Megestrol Acetate. Given below are the details of the strengths of this generic introduced by Xttrium Labs Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
40MG/ML | suspension | Prescription | ORAL | AB | Nov 1, 2004 |